Biotech News
A growing number of families in Phoenix and across Arizona are seeking independent medical examinations through private autopsy services to find definitive answers following the loss of a loved one.
First Commercial Deployment of FDA-Cleared AI-Guided TMS Navigation System, Expanded FDA Pathway for NRX-101, and Growing Commercial Infrastructure Highlight Accelerating Momentum for NRx Pharmaceuticals (N A S D A Q: NRXP)
TORONTO - -- An open Bayesian Causal Atlas now reports, for every disease it covers — including non-fatal conditions — the best-case modelled reduction achievable when all applicable beneficial interventions are combined under a Pearl structural...
Cosmos Health Inc. (N A S D A Q: COSM): 18 Series Nutraceutical Expansion, Record Q1 Results, EIB Financing Initiative, AI-Powered Drug Development, And Strong Long-Term Financial Guidance Position Cosmos Health For Potential Multi-Year Expansion
Cosmos Health Inc. (N A S D A Q: COSM): Veterinary Expansion, Proprietary Healthcare Brands, AI-Powered Drug Development, Telehealth Growth, and Strong Financial Guidance Position Cosmos Health for Potential Multi-Year Expansion
Expanding HOPE Therapeutics Network Positions NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP for Potential Breakout 2026 Growth
NRx Pharmaceuticals, Inc.Improved Financial Position, Commercial Ketamine Manufacturing, FDA Progress, and Expanding Neuroplastic Therapy Infrastructure Position $NRXP for a Potential Breakout Phase
Commercial-Ready Ketamine Production, FDA Alignment, and Expanding AI Neurotherapy Platform Position $NRXP at the Center of a Multi-Billion-Dollar Mental Health Transformation
Two day longevity, performance, faith and purpose experience returns to the James L. Knight Center in downtown Miami on October 10 & 11, 2026, anchored by Title Sponsor AllCore360°.
NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP: Dual FDA Pathways, and an Expanding AI-Driven Treatment Ecosystem Position NRXP at the Forefront of a Multi-Billion-Dollar Mental Health Transformation
Proprietary Stem Cell Platform Meets Institutional-Grade AI Infrastructure—Positioning $KALA at the Center of a Massive, Underserved $167B R&D Opportunity
Breakthrough Regulatory Alignment Now Meets Cutting-Edge Robotic Brain Therapy—Positioning $NRXP at the Intersection of Pharma, AI, and National Defense